Abstract: Click HereDavid Brayden is a Full Professor (Advanced Drug Delivery) at the School of Veterinary Medicine, University College Dublin (UCD) and also a Fellow of the UCD Conway Institute of Biotechnology. Following a Ph.D. in Pharmacology at the University of Cambridge, UK (1989), and a post-doctoral research fellowship at Stanford University, CA, he set up Elan Biotechnology Research’s in vitro pharmacology laboratory in Dublin (1991). At Elan, he became a senior scientist and project manager of several of Elan's Joint-Venture drug delivery research collaborations with US biotech companies. In 2001, he joined UCD as a lecturer in veterinary pharmacology and was appointed Associate Professor in 2006 and Full Professor in 2014. He was the Director of the Science Foundation Ireland (SFI) Research Cluster (The Irish Drug Delivery Research Network) from 2007-2013, was the Deputy Coordinator of an FP7 Consortium on oral peptides in nanoparticles (“TRANS-INT”, 2012-2017), and is currently a Co-Lead Principal Investigator in “CURAM”, SFI’s Centre for Medical Devices (2014-2020, www.curamdevices.ie ). He was made a Fellow of the Controlled Release Society in 2012 and will become a Fellow of the AAPS at the 2017 annual meeting. He is the author or co-author of more than 200 research publications and patents. Professor Brayden serves on the Editorial Advisory Boards of Drug Discovery Today, European Journal of Pharmaceutical Sciences, Advanced Drug Delivery Reviews and the Journal of Veterinary Pharmacology and Therapeutics, and is a Senior Associate Editor of Therapeutic Delivery. Professor Brayden also works as an independent consultant for Pharma companies.
1:20 PM–2:05 PM Nov 14, 2017
San Diego Convention Center - Ballroom 20BC